clinical trial · NCT05579574
A Study to Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol [EE]/Norethindrone [NET]) in Healthy Female Participants
Bristol-Myers Squibb·phase1·completed·n = 42
Healthy ParticipantsBMS-986322Loestrin
brief summary
The purpose of this study is to evaluate the effect of multiple doses of BMS-986322 on the pharmacokinetics (PK) of Loestrin components in healthy female participants.
started
Oct 21, 2022
primary completion
Jun 1, 2023
completion
Jun 1, 2023
last updated
Aug 18, 2023
official title
An Open-Label, Single-Sequence, Crossover Study to Investigate the Interaction of Multiple Doses of BMS-986322 at Steady State and Multiple Doses of a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol